News Archives | Future Medicine India


HIV study participants report beneficial social impact: HVTN analysis

Participants in HIV prevention trials feel good when helping others, found a NIAID-funded HIV Vaccine Trials Network (HVTN) cross-protocol analysis.

Read More..

India reports 36,594 cases on Thursday amid fears of a second wave

India’s total COVID-19 case tally rose to 95,71,559 with 36,594 new infections in last 24 hours. While the death toll mounted to 1,39,188 with 540 new deaths. Total active cases stand at 4,16,082.


Phase 2b studies for antisense molecule AZD8233 to treat dyslipidemia begins: AstraZeneca

AstraZeneca has launched a phase IIb clinical trial of the investigational antisense agent, ION449 (AZD8233), in patients with dyslipidemia.


COVID-19 case count soars in Kerala; drops in Delhi

India reported 35,506 fresh COVID-19 cases pushing the cumulative case tally to 95,35,234. The number of active infections stood at 4,21,604 with 40,908 people getting cured/discharged yesterday and 526 succumbing to the infection. The overall recoveries have reached 89,72,711 while the deaths have escalated to 1,38,686.


India’s overall COVID-19 case count crosses 36K on Tuesday

India saw 36,456 fresh COVID-19 infections on Tuesday. The cumulative case tally now stands at 94,99,710 with 4,27,524 active infections. As many as 43,203 recoveries were reported during the day taking the overall recoveries to 89,31,798. With 500 new deaths the fatalities rose to 1,38,159.


Lonafarnib gets FDA nod for treatment of progeria

The US FDA has recently approved lonafarnib (Zokinvy) as the first-ever treatment for progeria, a rare and fatal paediatric disease, characterized by dramatic, rapid ageing beginning in childhood.


Kerala, Himachal report higher number of COVID-19 cases on Sunday

India reported 39,036 new COVID-19 incidences with Kerala an Himachal Pradesh record ing a higher number of fresh SARS-CoV-2 infections on Sunday.